PDG104 DECREASING NUMBER OF PRESCRIPTIONS AFTER THEY BECAME MANDATORY AND THEIR VALIDITY PERIOD WAS EXTENDED TO TWO YEARS: CASE FINLAND SINCE 2017 von Jormanainen, V., Relander, T.

Volltext

PHP189 - NATIONAL MY KANTA PAGES PATIENT PORTAL SERVICE: IMPLEMENTATION, USE AND USERS IN 2010-2017 IN FINLAND von Jormanainen, V., Lindgren, M.

Volltext

COVID-19 pandemic in Finland – Preliminary analysis on health system response and economic consequences von Tiirinki, Hanna, Tynkkynen, Liina-Kaisa, Sovala, Markus, Atkins, Salla, Koivusalo, Meri, Rautiainen, Pauli, Jormanainen, Vesa, Keskimäki, Ilmo

Volltext

Anabolic-androgenic steroid use among young Finnish males von Mattila, V. M., Rimpelä, A., Jormanainen, V., Sahi, T., Pihlajamäki, H.

Volltext

An association between socioeconomic, health and health behavioural indicators and fractures in young adult males von MATTILA, V. M, JORMANAINEN, V, SAHI, T, PIHIAJAMAKI, H

Volltext

P158 Increase of medication usage for asthma, COPD and rhinitis during three decades in finland von Mattila, T, Jormanainen, V, Vasankari, T, Toppila-Salmi, S, Lammi, A, Herse, F, Haahtela, T, Erhola, M

Volltext

Impact of a CE-marked medical software sensor on SARS-CoV-2 disease pandemic progression estimation von Limingoja, L, Antila, KM, Jormanainen, V, Jägerroos, V, Soininen, L, Nordlund, H, Vepsäläinen, K, Kaikkonen, R, Lallukka, T

Volltext

Physicians' database searches as a tool for early detection of epidemics von Jormanainen, V, Jousimaa, J, Kunnamo, I, Ruutu, P

Volltext

The First Five Months Of National Prescription Monitoring In Finland von Jormanainen, VJ, Lindgren, M

Volltext

PHP279 - The First Five Months Of National Prescription Monitoring In Finland von Jormanainen, VJ, Lindgren, M

Volltext

The risk of Guillain–Barré syndrome following infection with Campylobacter jejuni von McCARTHY, N., ANDERSSON, Y., JORMANAINEN, V., GUSTAVSSON, O., GIESECKE, J.

Volltext

PMS66 PENETRATION OF MONOCLONAL ANTIBODIES ONTO FINNISH PHARMACEUTICAL MARKET von Kannisto, HE, Jormanainen, V, Happonen, P

Volltext

PCV27 COST-EFFECTIVENESS OF BUPROPION IN SMOKING CESSATION IN FINLAND von Hahl, J, Jormanainen, V

Volltext

PHP10 PHARMACY AND HOSPITAL MARKET PERFORMANCE INDICATORS IN FINLAND 1995–2007 von Jormanainen, V, Kannisto, H, Mäntyranta, T

Volltext

Anabolic-androgenic steroid use among young Finnish males: Anabolic-androgenic steroid use in Finnish males von Mattila, V. M., Rimpelä, A., Jormanainen, V., Sahi, T., Pihlajamäki, H.

Volltext

PCN28 ECONOMIC EVALUATION OF SWITCHING TO EXEMESTANE AT 2-3 YEARS VERSUS CONTINUING TAMOXIFEN AS ADJUVANT THERAPY IN EARLY BREAST CANCER: A FINNISH PERSPECTIVE von Fàrkkilà, N, Kotomäki, T, Jormanainen, V

Volltext

PHP19 DRUG PRICE INDICES 1980–2005 IN FINLAND von Hahl, J, Aaltonen, S, Jormanainen, V

Volltext

PND14 COST-EFFECTIVENESS OF PREGABALIN ADD-ON MEDICATION IN PATIENTS WITH REFRACTORY PARTIAL EPILEPSY IN FINLAND von Linden, K, Kotomaki, T, Sintonen, S, Jormanainen, V

Volltext

PHP1 RETAIL PRICES DECREASED 30% IN FINLAND IN 1994-2003 EVEN BEFORE INTRODUCTION OF GENERIC SUBSTITUTIONS COHORT ANALYSIS von Jormanainen, V, Hahl, J, Eränkö, P

Volltext

Smoking. Decreasing the prevalence of smoking among Finnish physicians von Jormanainen, V.

Volltext